Red bean extracts protect rats against intestinal inflammatory damage

Area of Science:

• Pharmacology
• Gastroenterology
• Natural Product Research

Background:

• Red beans are a dietary staple in Korean cuisine.
• The butanol fraction of red bean ethanol extracts (BF-RBEE) exhibits known anti-inflammatory and anti-septic properties.
• Intestinal inflammation, such as colitis, presents a significant health challenge.

Purpose of the Study:

• To investigate the intestinal anti-inflammatory activity of BF-RBEE.
• To elucidate the mechanisms underlying BF-RBEE's effects in a rat model of colitis.
• To compare the efficacy of BF-RBEE with a standard anti-inflammatory drug, prednisolone.

Main Methods:

• Acetic acid-induced colitis was established in a rat model.
• Rats were orally treated with BF-RBEE (100 mg/kg) or prednisolone (1 mg/kg).
• Inflammatory markers including myeloperoxidase activity, malondialdehyde levels, glutathione levels, and mRNA expression of nitric oxide synthase (NOS), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) were assessed.

Main Results:

• BF-RBEE treatment significantly suppressed body weight loss and reduced intestinal inflammatory damage in colitic rats.
• BF-RBEE normalized elevated myeloperoxidase activity and malondialdehyde levels, while restoring reduced glutathione levels.
• The extract inhibited acetic acid-induced increases in mRNA levels of NOS, IL-1β, and TNF-α, similar to prednisolone's effects.

Conclusions:

• BF-RBEE demonstrates significant intestinal anti-inflammatory effects in a rat model of colitis.
• The findings suggest that BF-RBEE exerts its protective effects by modulating key inflammatory pathways.
• Red beans, through extracts like BF-RBEE, hold potential as a therapeutic agent for intestinal inflammatory diseases.